Evidence map›Paper›PMID 34164935›Full record

Trial reportJournal of the International AIDS Society2021

Project Khanya: results from a pilot randomized type 1 hybrid effectiveness-implementation trial of a peer-delivered behavioural intervention for ART adherence and substance use in HIV care in South Africa.

Jessica F Magidson, John A Joska, Jennifer M Belus, Lena S Andersen, Kristen S Regenauer, Alexandra L Rose, Bronwyn Myers, Sybil Majokweni, Conall O'Cleirigh, Steven A Safren

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 6 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 6 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Jessica F MagidsonDepartment of Psychology, University of Maryland, College Park, MD, USA.ORCID 0000-0002-3513-3255
John A JoskaHIV Mental Health Research Unit, Division of Neuropsychiatry, Department of Psychiatry and Mental Health, Groote Schuur Hospital, Cape Town, South Africa.
Jennifer M BelusDepartment of Psychology, University of Maryland, College Park, MD, USA.
Lena S AndersenHIV Mental Health Research Unit, Division of Neuropsychiatry, Department of Psychiatry and Mental Health, Groote Schuur Hospital, Cape Town, South Africa.
Kristen S RegenauerDepartment of Psychology, University of Maryland, College Park, MD, USA.
Alexandra L RoseDepartment of Psychology, University of Maryland, College Park, MD, USA.
Bronwyn MyersAlcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Division of Addiction Psychiatry, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.ORCID 0000-0003-0235-6716
Sybil MajokweniHIV Mental Health Research Unit, Division of Neuropsychiatry, Department of Psychiatry and Mental Health, Groote Schuur Hospital, Cape Town, South Africa.
Conall O'CleirighDepartment of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Steven A SafrenDepartment of Psychology, University of Miami, Miami, FL, USA.ORCID 0000-0002-0121-0806
University of Maryland, College Park · USGroote Schuur Hospital · ZAHarvard University · USSouth African Medical Research Council · ZAUniversity of Miami · US

Funding

University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)P30MH116867 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI SAFREN, STEVEN A · 2019 to 2023
$6.5M
Nurse-Delivered CBT for Depression-Adherence in HIV Primary Care S. AfricaR01MH103770 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI O'CLEIRIGH, CONALL MICHAEL, SAFREN, STEVEN A · 2015 to 2019
$3.1M
Hybrid Effectiveness-Implementation Trial for ART Adherence and Substance Use in HIV Care in South AfricaK23DA041901 · NIDA · UNIV OF MARYLAND, COLLEGE PARK · PI MAGIDSON, JESSICA F · 2016 to 2020
$1.0M
Addressing psychosocial comorbidities in HIV treatment and preventionK24DA040489 · NIDA · UNIVERSITY OF MIAMI CORAL GABLES · PI SAFREN, STEVEN A · 2016 to 2020
$931k
Effectiveness and implementation of pre-training interpersonal skills assessment of community health workers in South Africa to predict post-training competence in mental health careF31MH123020 · NIMH · UNIV OF MARYLAND, COLLEGE PARK · PI ROSE, ALEXANDRA LEAH · 2021 to 2023
$127k
NIDA NIH HHS K23 DA041901NIDA NIH HHS K24 DA040489NIMH NIH HHS F31 MH123020NIMH NIH HHS P30 MH116867NIMH NIH HHS R01 MH103770
6 · The paper itself

Abstract

introductionSouth Africa (SA) has the highest number of people living with HIV (PLWH) globally, and a significant burden of alcohol and other drug use (AOD). Although integrating AOD treatment into HIV care may improve antiretroviral therapy (ART) adherence, this is not typically routine practice in SA or other low-resource settings. Identifying interventions that are feasible and acceptable for implementation is critical to improve HIV and AOD outcomes.

methodsA pilot randomized hybrid type 1 effectiveness-implementation trial (N = 61) was conducted to evaluate the feasibility and acceptability of Khanya, a task-shared, peer-delivered behavioral intervention to improve ART adherence and reduce AOD in HIV care in SA. Khanya was compared to enhanced treatment as usual (ETAU), a facilitated referral to on-site AOD treatment. Implementation outcomes, defined by Proctor's model, included feasibility, acceptability, appropriateness and fidelity. Primary pilot effectiveness outcomes were ART adherence at post-treatment (three months) measured via real-time electronic adherence monitoring, and AOD measured using biomarker and self-report assessments over six months. Data collection was conducted from August 2018 to April 2020. RESULTS AND DISCUSSION: Ninety-one percent of participants (n = 56) were retained at six months. The intervention was highly feasible, acceptable, appropriate and delivered with fidelity (>90% of components delivered as intended by the peer). There was a significant treatment-by-time interaction for ART adherence (estimate = -0.287 [95% CI = -0.507, -0.066]), revealing a 6.4 percentage point increase in ART adherence in Khanya, and a 22.3 percentage point decline in ETAU. Both groups evidenced significant reductions in alcohol use measured using phosphatidylethanol (PEth) (F(2,101) = 4.16, p = 0.01), significantly decreased likelihood of self-reported moderate or severe AOD (F(2,104) = 7.02, p = 0.001), and significant declines in alcohol use quantity on the timeline follow-back (F(2,102) = 21.53, p < 0.001). Among individuals using drugs and alcohol, there was a greater reduction in alcohol use quantity in Khanya compared to ETAU over six months (F(2,31) = 3.28, p = 0.05).

conclusionsResults of this pilot trial provide initial evidence of the feasibility and acceptability of the Khanya intervention for improving adherence in an underserved group at high risk for ongoing ART non-adherence and HIV transmission. Implementation results suggest that peers may be a potential strategy to extend task-sharing models for behavioral health in resource-limited, global settings.

Indexed as

HIV InfectionsSubstance-Related DisordersHumansMedication AdherencePilot ProjectsSouth Africaantiretroviral therapy adherenceglobal mental healthHIVimplementation scienceSouth Africasubstance use

Identifiers

PMID34164935
PMCPMC8222840
OpenAlexW3175788566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.